Folic acid in pregnancy and fetal outcomes

References

• Al-Gazali L I, Padmanabhan R, Melnyk S, Yi P, Pogribny I P, Pogribna M, et al. Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. American Journal of Medical Genetics 2001; 103: 128–132
   PubMed Web of Science ®Google Scholar
• American Cancer Society. 2005, Available at: http://www.cancer.org/docroot/home/index.asp (Accessed 1 May 2005).
   Google Scholar
• Badovinac R L, Werler M M, Williams P L, Kelsey K T, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Research A. Clinical and Molecular Teratology 2007; 79: 8–15
   PubMed Web of Science ®Google Scholar
• Bailey L. Folate and vitamin B12 recommended intakes and status in the United States. Nutrition Review 2001; 62: S14–S20
   Web of Science ®Google Scholar
• Baird P A. Neural tube defects in the Sikhs. American Journal of Medical Genetics 1983; 16: 49–56
   PubMed Web of Science ®Google Scholar
• Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population. Molecular Genetics and Metabolism 2000; 70: 45–52
   PubMed Web of Science ®Google Scholar
• Barkai G, Arbuzova S, Berkenstadt M, Heifetz S, Cuckle H. Frequency of Down's syndrome and neural-tube defects in the same family. Lancet 2003; 361: 1331–1335
   PubMed Web of Science ®Google Scholar
• Beaty T H, Wang H, Hetmanski J B, Fan Y T, Zeiger J S, Liang K Y, et al. A case-control study of nonsyndromic oral clefts in Maryland. Annals of Epidemiology 2001; 11: 434–442
   PubMed Web of Science ®Google Scholar
• Berry R J, Li Z, Erickson J D, Li S, Moore C A, Wang H, et al. Prevention of neural-tube defects with folic acid in China. China – U.S. Collaborative Project for Neural Tube Defect Prevention. New England Journal of Medicine 1999; 341: 1485–1490
   PubMed Web of Science ®Google Scholar
• Botto L D, Khoury M J, Mulinare J, Erickson J D. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Paediatrics 1996; 98: 911–917
   PubMed Web of Science ®Google Scholar
• Botto L D, Moore C A, Khoury M J, Erickson J D. Neural-tube defects. New England Journal of Medicine 1999; 341: 1509–1519
   PubMed Web of Science ®Google Scholar
• Botto L D, Mulinare J, Erickson J D. Occurrence of congenital heart defects in relation to maternal multivitamin use. American Journal of Epidemiology 2000; 151: 878–884
   PubMed Web of Science ®Google Scholar
• Botto L D, Mulinare J, Erickson J D. Occurrence of omphalocele in relation to maternal multivitamin use: a population-based study. Paediatrics 2002; 109: 904–908
   PubMed Web of Science ®Google Scholar
• Botto L D, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. American Journal of Epidemiology 2000; 151: 862–877
   PubMed Web of Science ®Google Scholar
• Bower C, Stanley F J. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Medical Journal of Australia 1989; 150: 613–619
   PubMed Web of Science ®Google Scholar
• Briggs R M. Vitamin supplementation as a possible factor in the incidence of cleft lip/palate deformities in humans. Clinics in Plastic Surgery 1976; 3: 647–652
   PubMedGoogle Scholar
• Bunin G R, Kuijten R R, Boesel C P, Buckley J D, Meadows A T. Maternal diet and risk of astrocytic glioma in children: a report from the Children's Cancer Group (United States and Canada). Cancer Causes Control 1994; 5: 177–187
   PubMed Web of Science ®Google Scholar
• Bunin G R, Kuijten R R, Buckley J D, Rorke L B, Meadows A T. Relation between maternal diet and subsequent primitive neuroectodermal brain tumours in young children. New England Journal of Medicine 1993; 329: 536–541
   PubMed Web of Science ®Google Scholar
• Butterworth C E, Jr, Bendich A. Folic acid and the prevention of birth defects. Annual Review of Nutrition 1996; 16: 73–97
   PubMed Web of Science ®Google Scholar
• Calzolari E, Bianchi F, Dolk H, Milan M. Omphalocele and gastroschisis in Europe: a survey of 3 million births 1980 – 1990. EUROCAT Working Group. American Journal of Medical Genetics 1995; 58: 187–194
   PubMed Web of Science ®Google Scholar
• Calzolari E, Bianchi F, Dolk H, Stone D, Milan M. Are omphalocele and neural tube defects related congenital anomalies? Data from 21 registries in Europe (EUROCAT). American Journal of Medical Genetics 1997; 72: 79–84
   PubMed Web of Science ®Google Scholar
• Calzolari E, Volpato S, Bianchi F, Cianciulli D, Tenconi R, Clementi M, et al. Omphalocele and gastroschisis: a collaborative study of five Italian congenital malformation registries. Teratology 1993; 47: 47–55
   PubMedGoogle Scholar
• Campbell N R. How safe are folic acid supplements?. Archives of Internal Medicine 1996; 156: 1638–1644
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Mortality and Morbidity Weekly Recommended Report 1992; 41: 1–7
   Google Scholar
• Centers for Disease Control and Prevention. Spina bifida and anencephaly before and after folic acid mandate – United States, 1995 – 1996 and 1999 – 2000. Mortality and Morbidity Weekly Report 2004; 3: 362–365
   Google Scholar
• Central Brain Tumor Registry of the United States. 2005, Available at: http://www.cbtrus.org/reports//2004–2005/2005report. pdf.
   Google Scholar
• Central Technical Co-ordinating Unit ICTCUI. Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research 2000; 112: 206–211
   PubMed Web of Science ®Google Scholar
• Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, et al. The effect of 677C → T and 1298A → C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. British Journal of Nutrition 2000; 83: 593–596
   PubMed Web of Science ®Google Scholar
• Christianson R E, van den Berg B J, Milkovich L, Oechsli F W. Incidence of congenital anomalies among white and black live births with long-term follow-up. American Journal of Public Health 1981; 71: 1333–1341
   PubMed Web of Science ®Google Scholar
• Christman J K, Sheikhnejad G, Dizik M, Abileah S, Wainfan E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 1993; 14: 551–557
   PubMed Web of Science ®Google Scholar
• Ciacci C, Cirillo M, Auriemma G, Di D G, Sabbatini F, Mazzacca G. Coeliac disease and pregnancy outcome. American Journal of Gastroenterology 1996; 91: 718–722
   PubMed Web of Science ®Google Scholar
• Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. Homocysteine in health and disease, R Carmel, D W Jacobson. Cambridge Press, Cambridge 2001; 63–78
   Google Scholar
• Conway H. Effect of supplemental vitamin therapy on the limitation of incidence of cleft lip and cleft palate in humans. Plastic Reconstructive Surgery and Transplant Bulletin 1958; 22: 450–453
   PubMedGoogle Scholar
• Correa-Villasenor A, Cragan J, Kucik J, O'Leary L, Siffel C, Williams L. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Research A. Clinical Molecular Teratology 2003; 67: 617–624
   PubMed Web of Science ®Google Scholar
• Crawford P, Appleton R, Betts T, Duncan J, Guthrie E, Morrow J. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure 1999; 8: 201–217
   PubMed Web of Science ®Google Scholar
• Czeizel A E. Folic acid and prevention of birth defects. Journal of the American Medical Association 1996a; 275: 1635–1636
   Web of Science ®Google Scholar
• Czeizel A E. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics 1996b; 62: 179–183
   PubMed Web of Science ®Google Scholar
• Czeizel A E, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Research A. Clinical Molecular Teratology 2004; 70: 853–861
   PubMed Web of Science ®Google Scholar
• Czeizel A E, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 1992; 327: 1832–1835
   PubMed Web of Science ®Google Scholar
• Czeizel A E, Dudas I, Fritz G, Tecsoi A, Hanck A, Kunovits G. The effect of periconceptional multivitamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives in Gynecology and Obstetrics 1992; 251: 181–185
   PubMed Web of Science ®Google Scholar
• Czeizel A E, Dudas I, Metneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Archives in Gynecology and Obstetrics 1994; 255: 131–139
   PubMed Web of Science ®Google Scholar
• Czeizel A E, Timar L, Sarkozi A. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 1999; 104: e66
   PubMed Web of Science ®Google Scholar
• Daly L E, Kirke P N, Molloy A, Weir D G, Scott J M. Folate levels and neural tube defects. Implications for prevention. Journal of the American Medical Association 1995; 274: 1698–1702
   PubMed Web of Science ®Google Scholar
• Daly S, Mills J L, Molloy A M, Conley M, Lee Y J, Kirke P N, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997; 350: 1666–1669
   PubMed Web of Science ®Google Scholar
• de Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P. Spina bifida, 677T → C mutation, and role of folate. Lancet 1995; 346: 1703
   PubMed Web of Science ®Google Scholar
• Douglas B. The role of environmental factors in the etiology of so-called congenital malformations. I. Deductions from the presence of cleft lip and palate in one of identical twins, from embryology and from animal experiments. Plastic Reconstructive Surgery and Transplant Bulletin 1958a; 22: 94–108
   PubMedGoogle Scholar
• Douglas B. The role of environmental factors in the etiology of so-called congenital malformations. II. Approaches in humans; study of various extragenital factors; theory of compensatory nutrients, development of regime for first trimester. Plastic Reconstructive Surgery and Transplant Bulletin 1958b; 22: 214–229
   PubMedGoogle Scholar
• Elwood J H. Major central nervous system malformations notified in Northern Ireland, 1969 to 1973. Developments in Medical Child Neurology 1976; 18: 512–520
   PubMed Web of Science ®Google Scholar
• Engbersen A M, Franken D G, Boers G H, Stevens E M, Trijbels F J, Blom H J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. American Journal of Human Genetics 1995; 56: 142–150
   PubMed Web of Science ®Google Scholar
• European Union. 2005, Online. Available at: http://europa.eu.int/comm/health/ph_projects/2001/rare_diseases/fp_raredis_2001_a2_ 01_en.pdf (accessed 1 May 2005).
   Google Scholar
• Fleming A. The role of folate in the prevention of neural tube defects: human and animal studies. Nutrition Review 2001; 59: S13–S20
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. 1996, Online. Available at: http://www.cfsan.fda.gov/∼lrd/fr96305c.html.
   Google Scholar
• Forrest J D. Epidemiology of unintended pregnancy and contraceptive use. American Journal of Obstetrics and Gynecology 1994; 170: 1485–1489
   PubMed Web of Science ®Google Scholar
• Frecker M, Fraser F C. Epidemiological studies of neural tube defects in Newfoundland. Teratology 1987; 36: 355–361
   PubMedGoogle Scholar
• French A E, Grant R, Weitzman S, Ray J G, Vermeulen M J, Sung L, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clinical Pharmacology and Therapeutics 2003; 74: 288–294
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom H J, Milos R, Goyette P, Sheppard C A, Matthews R G, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111–113
   PubMed Web of Science ®Google Scholar
• Goh Y I, Bollano E, Einarson T R, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. Journal of Obstetrics and Gynecology of Canada 2006; 28: 680–689
   PubMedGoogle Scholar
• Goh Y I, Bollano E, Einarson T R, Koren G. Prenatal multivitamin supplementation and rates of paediatric cancers: a meta-analysis. Clinical Pharmacology and Therapeutics 2007; 81: 685–691
   PubMed Web of Science ®Google Scholar
• Government of Canada. 2005, Online. Available at: http://www.hc-sc.gc.ca/hp-gs/know-savoir/folic-folique_e.html.
   Google Scholar
• Greenberg F, James L M, Oakley G P, Jr. Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps. American Journal of Obstetrics and Gynecology 1983; 145: 570–573
   PubMed Web of Science ®Google Scholar
• Gregory J F, 3rd. The bioavailability of folate. Folate in health and disease, L B Bailey. Marcel Dekker Inc., New York 1995; 195–236
   Google Scholar
• Gregory J F, III. Case study: folate bioavailability. Journal of Nutrition 2001; 131: 1376S–1382S
   PubMed Web of Science ®Google Scholar
• Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. European Journal of Pediatrics 1998; 157: 445–450
   PubMed Web of Science ®Google Scholar
• Hayes C, Werler M M, Willett W C, Mitchell A A. Case-control study of periconceptional folic acid supplementation and oral clefts. American Journal of Epidemiology 1996; 143: 1229–1234
   PubMed Web of Science ®Google Scholar
• Health Canada. Congenital anomalies in Canada – A Perinatal Health Report. Minister of Public Works and Government Services Canada, Ottawa 2002
   Google Scholar
• Heath C W, Jr. Cytogenetic observations in vitamin B12 and folate deficiency. Blood 1966; 27: 800–815
   PubMed Web of Science ®Google Scholar
• Herbert V, Zalusky R. Interrelations of vitamin B12 and folic acid metabolism: folic acid clearance studies. Journal of Clinical Investigation 1962; 41: 1263–1276
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Werler M M, Walker A M, Mitchell A A. Folic acid antagonists during pregnancy and the risk of birth defects. New England Journal of Medicine 2000; 343: 1608–1614
   PubMed Web of Science ®Google Scholar
• Hibbard B M. Folates and the fetus. South African Medical Journal 1975; 49: 1223–1226
   PubMed Web of Science ®Google Scholar
• Hobbs C A, Sherman S L, Yi P, Hopkins S E, Torfs C P, Hine R J, et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. American Journal of Human Genetics 2000; 67: 623–630
   PubMed Web of Science ®Google Scholar
• Hoffbrand A V, Weir D G. The history of folic acid. British Journal of Haematology 2001; 113: 579–589
   PubMed Web of Science ®Google Scholar
• Holmes-Siedle M, Dennis J, Lindenbaum R H, Galliard A. Long term effects of periconceptional multivitamin supplements for prevention of neural tube defects: a seven to 10 year follow up. Archives of Diseases in Childhood 1992; 67: 1436–1441
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academy Press, Washington 1998
   Google Scholar
• Itikala P R, Watkins M L, Mulinare J, Moore C A, Liu Y. Maternal multivitamin use and orofacial clefts in offspring. Teratology 2001; 63: 79–86
   PubMedGoogle Scholar
• Jacques P F, Bostom A G, Williams R R, Ellison R C, Eckfeldt J H, Rosenberg I H, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7–9
   PubMed Web of Science ®Google Scholar
• James S J, Pogribna M, Pogribny I P, Melnyk S, Hine R J, Gibson J B, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. American Journal of Clinical Nutrition 1999; 70: 495–501
   PubMed Web of Science ®Google Scholar
• Johnson K C, Rouleau J. Temporal trends in Canadian birth defects birth prevalences, 1979 – 1993. Canadian Journal of Public Health 1997; 88: 169–176
   PubMed Web of Science ®Google Scholar
• Kapur B, Bar-Oz B, Koren G, and Nguyen P. Folate fortification and supplementation – are we there yet? [abstract]. Canadian Journal of Clinical Pharmacology 2007; 14: 104–204
   Google Scholar
• Kruschwitz H L, McDonald D, Cossins E A, Schirch V. 5-Formyltetrahydropteroylpolyglutamates are the major folate derivatives in Neurospora crassa conidiospores. Journal of Biological Chemistry 1994; 269: 28757–28763
   PubMed Web of Science ®Google Scholar
• Lammer E J, Shaw G M, Iovannisci D M, Finnell R H. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Research A. Clinical and Molecular Teratology 2004; 70: 846–852
   PubMed Web of Science ®Google Scholar
• Lary J M, Edmonds L D. Prevalence of spina bifida at birth – United States, 1983 – 1990: a comparison of two surveillance systems. Morbidity and Mortality Weekly Report. CDC Surveillance Summaries 1996; 45: 15–26
   PubMedGoogle Scholar
• Laurence K M, James N, Miller M, Campbell H. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. British Medical Journal 1980; 281: 1592–1594
   PubMed Web of Science ®Google Scholar
• Laurence K M, James N, Miller M H, Tennant G B, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. British Medical Journal (Clinical Research ed.) 1981; 282: 1509–1511
   PubMed Web of Science ®Google Scholar
• Li D K, Daling J R, Mueller B A, Hickok D E, Fantel A G, Weiss N S. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995; 6: 212–218
   PubMed Web of Science ®Google Scholar
• Lin A E, Herring A H, Amstutz K S, Westgate M N, Lacro R V, Al-Jufan M, et al. Cardiovascular malformations: changes in prevalence and birth status, 1972 – 1990. American Journal of Medical Genetics 1999; 84: 102–110
   PubMed Web of Science ®Google Scholar
• Lloyd M E, Carr M, McElhatton P, Hall G M, Hughes R A. The effects of methotrexate on pregnancy, fertility and lactation. Quarterly Journal of Medicine 1999; 92: 551–563
   Google Scholar
• Locksmith G J, Duff P. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstetrics and Gynecology 1998; 91: 1027–1034
   PubMed Web of Science ®Google Scholar
• Loffredo C A. Epidemiology of cardiovascular malformations: prevalence and risk factors. American Journal of Medical Genetics 2000; 97: 319–325
   PubMed Web of Science ®Google Scholar
• Malatack J J, Moran M M, Moughan B. Isolated congenital malabsorption of folic acid in a male infant: insights into treatment and mechanism of defect. Pediatrics 1999; 104(5 Pt 1)1133–1137
   PubMed Web of Science ®Google Scholar
• Marden P M, Smith D W, McDonald M J. Congenital anomalies in the newborn infant, including minor variations. A study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin. Journal of Pediatrics 1964; 64: 357–671
   PubMed Web of Science ®Google Scholar
• McGuirk C K, Westgate M N, Holmes L B. Limb deficiencies in newborn infants. Pediatrics 2001; 108: E64
   PubMed Web of Science ®Google Scholar
• Metz J, Stevens K, Krawitz S, Brandt V. The plasma clearance of injected doses of folic acid as an index of folic acid deficiency. Journal of Clinical Pathology 1961; 14: 622–625
   PubMed Web of Science ®Google Scholar
• Mills J L, Rhoads G G, Simpson J L, Cunningham G C, Conley M R, Lassman M R, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. New England Journal of Medicine 1989; 321: 430–435
   PubMed Web of Science ®Google Scholar
• Milunsky A, Jick H, Jick S S, Bruell C L, MacLaughlin D S, Rothman K J, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. Journal of the American Medical Association 1989; 262: 2847–2852
   PubMed Web of Science ®Google Scholar
• Mitchell D C, Vilter R W, Vilter C F. Hypersensitivity to folic acid. Annals of Internal Medicine 1949; 31: 1102–1105
   PubMed Web of Science ®Google Scholar
• Mitchell H K, Snell E E, Williams R J. Journal of the American Chemical Society 63:1941: the concentration of ‘folic acid’ by Herschel K. Mitchell, Esmond E. Snell, and Roger J. Williams. Nutrition Review 1988; 46: 324–325
   PubMedGoogle Scholar
• Molloy A M, Daly S, Mills J L, Kirke P N, Whitehead A S, Ramsbottom D, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349: 1591–1593
   PubMed Web of Science ®Google Scholar
• Moore C V, Bierbaum O S, Welch A D, Wright L D. The activity of synthetic Lactobacillus carei factor (‘folic acid’) as an antipernicious anaemia substance. I. Observations on four patients, two with Addisonian perivirus anaemias, one with nontropical sprue and one with pernicious anaemia of pregnancy. Journal of Laboratory and Clinical Medicine 1945; 30: 1056–1069
   PubMed Web of Science ®Google Scholar
• Moore K, Persaud T. The developing human: clinically oriented embryology. WB Saunders, Philadelphia 1998
   Google Scholar
• Motulsky A G. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. American Journal of Human Genetics 1996; 58: 17–20
   PubMed Web of Science ®Google Scholar
• MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338: 131–137
   PubMed Web of Science ®Google Scholar
• Mudd S. Vascular disease and homocysteine metabolism. Genetic susceptibility to environmental factors: a challenge for public intervention, U Smith, S Eriksson, F Lindgarde. Almqvist and Wiksell, Stockholm 1988; 11–24
   Google Scholar
• Mulinare J, Cordero J F, Erickson J D, Berry R J. Periconceptional use of multivitamins and the occurrence of neural tube defects. Journal of the American Medical Association 1988; 260: 3141–3145
   PubMed Web of Science ®Google Scholar
• Myers M F, Li S, Correa-Villasenor A, Li Z, Moore C A, Hong S X, et al. Folic acid supplementation and risk for imperforate anus in China. American Journal of Epidemiology 2001; 154: 1051–1056
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. 2005, Online. Available at: http://www.cancer.gov/cancerinfo/pdq/treatment/childmedulloblastoma/Keypoint1.
   Google Scholar
• Ou C Y, Stevenson R E, Brown V K, Schwartz C E, Allen W P, Khoury M J, et al. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. American Journal of Medical Genetics 1996; 63: 610–614
   PubMed Web of Science ®Google Scholar
• Peer L A, Bryan W H, Strean L P, Walker J C, Jr, Bernhard W G, Peck G C. Induction of cleft palate in mice by cortisone and its reduction by vitamins. Journal of the International College of Surgeons 1958; 30: 249–254
   PubMedGoogle Scholar
• Peer L, Gordon H, Bernhard W. Effect of vitamins on human teratology. Journal of Plastic and Reconstructive Surgery 1964; 34: 358–362
   Google Scholar
• Pogribny I P, Basnakian A G, Miller B J, Lopatina N G, Poirier L A, James S J. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Research 1995; 55: 1894–1901
   PubMed Web of Science ®Google Scholar
• Pogribny I P, Miller B J, James S J. Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat. Cancer Letters 1997a; 115: 31–38
   PubMed Web of Science ®Google Scholar
• Pogribny I P, Muskhelishvili L, Miller B J, James S J. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 1997b; 18: 2071–2076
   PubMed Web of Science ®Google Scholar
• Preston-Martin S, Pogoda J M, Mueller B A, Holly E A, Lijinsky W, Davis R L. Maternal consumption of cured meats and vitamins in relation to paediatric brain tumours. Cancer Epidemiology, Biomarkers and Prevention 1996; 5: 599–605
   PubMed Web of Science ®Google Scholar
• Preston-Martin S, Pogoda J M, Mueller B A, Lubin F, Holly E A, Filippini G, et al. Prenatal vitamin supplementation and risk of childhood brain tumours. International Journal of Cancer 1998, Suppl 11: 17–22
   Google Scholar
• Preston-Martin S, Yu M C, Benton B, Henderson B E. N-Nitroso compounds and childhood brain tumours: a case-control study. Cancer Research 1982; 42: 5240–5245
   PubMed Web of Science ®Google Scholar
• Ramakrishnan U. Micronutrients and pregnancy outcome: a review of the literature. Nutrition Research 1999; 19: 103–159
   Web of Science ®Google Scholar
• Rivey M P, Schottelius D D, Berg M J. Phenytoin-folic acid: a review. Drug Intell Clin Pharm 1984; 18: 292–301
   PubMedGoogle Scholar
• Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 1982; 2: 937
   PubMed Web of Science ®Google Scholar
• Rosenblatt D. Inherited disorders of folate transport and metabolism. The metabolic and molecular basis of inherited disease, C R Scriver, A L Beaudet, W S Sly, D Valle. McGraw-Hill, New York 1995; 3111–3149
   Google Scholar
• Scanlon K S, Ferencz C, Loffredo C A, Wilson P D, Correa-Villasenor A, Khoury M J, et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 1998; 9: 95–98
   PubMed Web of Science ®Google Scholar
• Scott J M, Weir D G, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. Ciba Foundation Symposium 1994; 181: 180–187
   PubMedGoogle Scholar
• Shaw G M, Jensvold N G, Wasserman C R, Lammer E J. Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983 – 1987. Teratology 1994; 49: 143–149
   PubMedGoogle Scholar
• Shaw G M, Lammer E J, Wasserman C R, O'Malley C D, Tolarova M M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995a; 346: 393–396
   PubMed Web of Science ®Google Scholar
• Shaw G M, O'Malley C D, Wasserman C R, Tolarova M M, Lammer E J. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. American Journal of Medical Genetics 1995b; 59: 536–545
   PubMed Web of Science ®Google Scholar
• Sheppard S, Nevin N C, Seller M J, Wild J, Smithells R W, Read A P, et al. Neural tube defect recurrence after ‘partial’ vitamin supplementation. Journal of Medical Genetics 1989; 26: 326–329
   PubMed Web of Science ®Google Scholar
• Shibuya K, Murray C JL. Congenital anomalies. C JL Murray. Harvard University Press, Boston 1998; 455–512
   Google Scholar
• Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe H L, et al. Trends in breast cancer by race and ethnicity. CA Cancer Journal for Clinicians 2006; 56: 168–183
   PubMed Web of Science ®Google Scholar
• Smithells R W. Incidence of congenital abnormalities in Liverpool, 1960 – 64. British Journal of Preventive and Social Medicine 1968; 22: 36–37
   PubMedGoogle Scholar
• Smithells R W, Nevin N C, Seller M J, Sheppard S, Harris R, Read A P, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983; 1: 1027–1031
   PubMed Web of Science ®Google Scholar
• Smithells R W, Sheppard S, Schorah C J. Vitamin deficiencies and neural tube defects. Archives of Disease in Childhood 1976; 51: 944–950
   PubMed Web of Science ®Google Scholar
• Smithells R W, Sheppard S, Schorah C J, Seller M J, Nevin N C, Harris R, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980; 1: 339–340
   PubMed Web of Science ®Google Scholar
• Smithells R W, Sheppard S, Schorah C J, Seller M J, Nevin N C, Harris R, et al. Vitamin supplementation and neural tube defects. Lancet 1981; 2: 1425
   PubMed Web of Science ®Google Scholar
• Spouge D, Baird P A. Imperforate anus in 700,000 consecutive liveborn infants. American Journal of Medical Genetics 1986, Suppl 2: 151–161
   PubMed Web of Science ®Google Scholar
• Stover P J. Physiology of folate and vitamin B12 in health and disease. Nutrition Reviews 2004; 62: S3–S12
   PubMed Web of Science ®Google Scholar
• Suh J R, Herbig A K, Stover P J. New perspectives on folate catabolism. Annual Review of Nutrition 2001; 21: 255–282
   PubMed Web of Science ®Google Scholar
• Sutherland G R, Ledbetter D H. Report of the committee on cytogenetic markers. Cytogenetics and Cell Genetics 1989; 51: 452–458
   PubMedGoogle Scholar
• Thompson S J, Torres M E, Stevenson R E, Dean J H, Best R G. Periconceptional multivitamin folic acid use, dietary folate, total folate and risk of neural tube defects in South Carolina. Annals of Epidemiology 2003; 13: 412–418
   PubMed Web of Science ®Google Scholar
• Thorne R N, Pearson A D, Nicoll J A, Coakham H B, Oakhill A, Mott M G, et al. Decline in incidence of medulloblastoma in children. Cancer 1994; 74: 3240–3244
   PubMed Web of Science ®Google Scholar
• Tolarova M, Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995; 51: 71–78
   PubMedGoogle Scholar
• Ulrich M, Kristoffersen K, Rolschau J, Grinsted P, Schaumburg E, Foged N. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part III. Congenital anomalies. An observational study. European Journal of Obstetrics, Gynecology and Reproductive Biology 1999; 87: 115–118
   PubMed Web of Science ®Google Scholar
• van der Put N M, Eskes T K, Blom H J. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Quarterly Journal of Medicine 1997; 90: 111–115
   Google Scholar
• van der Put N M, Steegers-Theunissen R P, Frosst P, Trijbels F J, Eskes T K, van den Heuvel L P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070–1071
   PubMed Web of Science ®Google Scholar
• van der Put N M, van den Heuvel L P, Steegers-Theunissen R P, Trijbels F J, Eskes T K, Mariman E C, et al. Decreased methylene tetrahydrofolate reductase activity due to the 677C → T mutation in families with spina bifida offspring. Journal of Molecular Medicine 1996; 74: 691–694
   PubMed Web of Science ®Google Scholar
• Van Dyke D C, Stumbo P J, Mary J B, Niebyl J R. Folic acid and prevention of birth defects. Developmental Medicine and Child Neurology 2002; 44: 426–469
   PubMed Web of Science ®Google Scholar
• Vergel R G, Sanchez L R, Heredero B L, Rodriguez P L, Martinez A J. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenatal Diagnosis 1990; 10: 149–152
   PubMed Web of Science ®Google Scholar
• Vilter R W, Spies T D, Koch M V. Further studies on folic acid in the treatment of macrocytic anaemia. 5th Medical Journal (Nashville) 1945; 38: 781–785
   Google Scholar
• Wagner C. Biochemical role of folate in cellular metabolism. Folate in health and disease, L B Bailey. Marcel Dekker Inc., New York 1995; 23–42
   Google Scholar
• Wainfan E, Poirier L A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Research 1992; 52: 2071s–2077s
   PubMed Web of Science ®Google Scholar
• Wald N J, Law M, Jordan R. Folic acid food fortification to prevent neural tube defects. Lancet 1998; 351: 834–835
   PubMed Web of Science ®Google Scholar
• Werler M M, Hayes C, Louik C, Shapiro S, Mitchell A A. Multivitamin supplementation and risk of birth defects. American Journal of Epidemiology 1999; 150: 675–682
   PubMed Web of Science ®Google Scholar
• Whitehead A S, Gallagher P, Mills J L, Kirke P N, Burke H, Molloy A M, et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Quarterly Journal of Medicine 1995; 88: 763–766
   Google Scholar
• Wills L, Mehta M M. Studies in ‘pernicious anaemia’ of pregnancy. I. Preliminary report. Indian Journal of Medical Research 1930; 17: 777–792
   Google Scholar
• Wills L. Treatment of ‘pernicious anaemia of pregnancy’ and ‘tropical anaemia’ with special reference to yeast extract as a curative agent. 1931. Nutrition 1991; 7: 323–327
   PubMed Web of Science ®Google Scholar
• Zhao R, Russell R G, Wang Y, Liu L, Gao F, Kneitz B, et al. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. Journal of Biological Chemistry 2001; 276: 10224–10228
   PubMed Web of Science ®Google Scholar